[1]
“COMPARISON OF OUTCOME IN METFORMIN WITH DAPAGLIFOZIN VERSUS METFORMIN WITH SITAGLIPTIN IN-TERM OF REDUCTION IN HBA1C IN TYPE 2 DIABETES MELLITUS”, FMHR, vol. 3, no. 4, pp. 1069–1073, Jun. 2025, Accessed: Aug. 17, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1763